Haemate P is indicated for prophylaxis and treatment of bleeding or bleeding following surgery.
Haemate P is presented as powder and solvent. The made up solution is to be given by injection or infusion into a vein.
Von Willebrand disease (VWD): Haemate P is used for the prevention and treatment of bleedings or surgical bleeding caused by the lack of von Willebrand factor, when desmopressin (DDAVP) treatment alone is ineffective or contra-indicated.
Haemophilia A (congenital factor VIII deficiency): Haemate P is used to prevent or to stop bleedings caused by the lack of factor VIII in the blood.
It may also be used in the management of acquired factor VIII deficiency and for treatment of patients with antibodies against factor VIII.
The active substance is human von Willebrand factor and human coagulation factor VIII.
Pack with 500 IU FVIII / 1200 IU VWF containing:
1 vial with powder
1 vial with 10 ml water for injections
1 filter transfer device 20/20
Administration set (inner box):
- 1 disposable 10 ml syringe
- 1 venipuncture set
- 2 alcohol swabs
- 1 non-sterile plaster>
The information presented above does not provide medical advice. It is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Seek professional medical advice to treat your condition.
Η εταιρεία CSL Behring εκπροσωπείται από την Prisum MONO στην Ρουμανία.